Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Norovirus capsid protein VP1 is the major structural protein forming the outer shell of noroviruses, a leading cause of acute viral gastroenteritis. VP1 self-assembles into an icosahedral capsid and interacts with host cell receptors such as histo-blood group antigens (HBGAs). The P2 subdomain mediates HBGA binding, a key determinant of strain-specific infectivity. Sequence diversity in P2 contributes to antigenic variation and immune evasion. VP1 is a key target for vaccine development, with virus-like particles (VLPs) based on VP1 showing promise as immunogens.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Norovirus Capsid Protein VP1 (VP1).